Interesting company - SINTX raised over usd $11 million in Q3 2020.
- OEM of silicon nitride ceramic, used in the manufacture of medical implants
- licensing agreement very recently signed with O2TODAY, a mask manufacturer
Although both ZEN and SINT have a doctor as CEO, the respective backgrounds are markedly different.
B. Sonny Bal, MD, JD, MBA, PhD Chairman of the Board, Chief Executive Officer, President & Principal Financial Officer
Dr. Sonny Bal has served on the Board of Directors of SINTX Technologies since February 2012, and as Chairman of the Board since August 2014. In October 2014, he was appointed the CEO & President of SINTX Technologies.
Dr. Bal previously served as Professor of Orthopaedic Surgery, and Adjunct Professor of Material Sciences at the University of Missouri. He has >20 years of clinical experience as an orthopaedic surgeon and attorney, and is affiliated with several professional organizations. In addition to serving on the editorial boards of peer-refereed journals, Dr. Bal has researched and published extensively in ceramic science, and continues that work.
Dr. Bal holds an M.D. from Cornell University, an M.B.A. from Northwestern University, a J.D. from the University of Missouri and a Ph.D in Materials Engineering from the Kyoto Institute of Technology.
|
